UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000016331
Receipt No. R000018951
Official scientific title of the study Utility of contrast-enhanced harmonic endoscopic ultrasonography for differential diagnosis of malignant from benign lymphadenopathy: a prospective study
Date of disclosure of the study information 2015/01/26
Last modified on 2017/02/10 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Utility of contrast-enhanced harmonic endoscopic ultrasonography for differential diagnosis of malignant from benign lymphadenopathy: a prospective study
Title of the study (Brief title) Utility of contrast-enhanced harmonic endoscopic ultrasonography for differential diagnosis of malignant from benign lymphadenopathy: a prospective study
Region
Japan

Condition
Condition Pancreatic carcinoma, Biliary carcinoma
Classification by specialty
Hepato-biliary-pancreatic medicine
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 This cohort study aimed to compare the diagnostic accuracy of contrast-enkhanecd harmonic EUS, standard EUS and color Doppler EUS in terms of differentiating malignant from benign lymph nodes.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes To compare the diagnostic accuracy of standard EUS, color Doppler EUS and CH-EUS in terms of the ability to differentiate malignant nodes from benign nodes.
Key secondary outcomes To compare the accuracy of CH-EUS and EUS-FNA in terms of N-stage diagnosis

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
100 years-old >
Gender Male and Female
Key inclusion criteria Cases with lymphadenopathy detected by EUS
Cases with pancreatobiliary tumors confirmed by the other imag9ng methods.
Written informed consent
ECOG performance stautus = 0-2
Key exclusion criteria Inapropriate to perform endoscopic ultrasonography
Faiulre of other organs (ASA: Grade 3, 4)
Inability to obtain informed consent
Target sample size 84

Research contact person
Name of lead principal investigator Masayuki Kitano
Organization Kinki University Faculty of Medicine
Division name Department of Gastroenterology and Hepatology
Address 377-2 Ohno-higashi, Osaka-sayama, Osaka, JAPAN
TEL 072-366-0221
Email m-kitano@med.kindai.ac.jp

Public contact
Name of contact person Masayuki Kitano
Organization Kinki University Faculty of Medicine
Division name Department of Gastroenterology and Hepatology
Address 377-2 Ohno-higashi, Osaka-sayama, Osaka, JAPAN
TEL 072-366-0221
Homepage URL
Email m-kitano@med.kindai.ac.jp

Sponsor
Institute Department of Gastroenterology and Hepatology, Kinki University Faculty of Medicine
Institute
Department

Funding Source
Organization The Japan Society for the Promotion of Science
Organization
Division
Category of Funding Organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 01 Month 26 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 09 Month 30 Day
Anticipated trial start date
2015 Year 01 Month 26 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information In consequtive patients with pancreatobiliary tumors acompanied by lymphadenopathy, contrast-enhanced harmonic EUS, conventional EUS and color Dopller EUS are perfrmed. Diagnostic abilities to identify lymph node metastases for all modalities are evaluated and compared.

Management information
Registered date
2015 Year 01 Month 25 Day
Last modified on
2017 Year 02 Month 10 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018951